FDA clearance for universal dual-target CAR-T candidate
Positive data from chronic scrotal content pain trial
Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
MetaVia collaborating with Syntekabio to boost drug options
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Ofichem expands capabilities with Swedish site acquisition
Genentech provides positive update on wet AMD drug
Concept Life Sciences and Fios Genomics partner to enhance complex data analysis in drug discovery
ESTEVE CDMO expands US footprint with Regis Technologies acquisition
Hepatocellular carcinoma in the crosshairs with new treatment